Biblio
KIR2DS4 and its variant KIR1D in KIR-AA genotype donors showed differential survival impact in patients with lymphoid disease after HLA-matched unrelated hematopoietic stem cell transplantation. Transplant Cell Ther. 2023.
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models. J Immunother Cancer. 2023;11(7).
. Enhancement of EGFR antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/SIRPα interactions. Cancer Sci. 2021.
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade. Hemasphere. 2024;8(2):e48.
EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies. Oncoimmunology. 2013;2(5):e24052.
. A Complement-Optimized EGFR Antibody Improves Cytotoxic Functions of Polymorphonuclear Cells against Tumor Cells. J Immunol. 2015.
. Complement in Antibody-Based Tumor Therapy. Crit Rev Immunol. 2014;34(3):199-214.
.